20. Swidsinski A., Mendling W., Loening-Baucke V., Ladhoff A., Swidsinski S., Hale L. P., Lochs H. Adherent biofilms in bacterial vaginosis // Obstetrics & Gynecology. 2005. Vol. 106, no. 5, part 1. P. 1013-1023.
21. McMillan A., Dell M., Zellar M. P., Cribby S., Martz S., Hong E., Fu J., Abbas A., Dang T., Miller W., Reid G. Disruption of urogenital biofilms by lactobacilli // Colloids and Surfaces B: Biointerfaces. 2011. Vol. 86, no. 1. P. 58-64. doi: 10.1016/j.colsurfb.2011.03.016.
22. Beigi R. H., Austin M. N., Meyn L. A., Krohn M. A., Hillier S. L. Antimicrobial resistance associated with the treatment of bacterial vaginosis // American journal of obstetrics and gynecology. 2004. Vol. 191, no. 4. P. 1123-1129.
23. Alves P., Castro J., Sousa C., Cereija T. B., Cerca N. Gardnerella vaginalis outcompetes 29 other bacterial species isolated from patients with bacterial vaginosis, using in an in vitro biofilm formation model // The Journal of infectious diseases. 2014. Vol. 210, no. 4. P. 593-596.
24. Манухин И.Б., Фириченко С.В., Смирнова С.О., Вученович Ю.Д. Микробиота влагалища: диагностика, влияние на здоровье женщины и коррекция нарушений. Учебное пособие для врачей, клинических ординаторов, аспирантов интернов. М. : ГлавПринт, 2015. С. 61-62.
25. Молчанов О.Л. Патогенетические особенности и клиника бактериального вагиноза // Акушерство и гинекология Санкт-Петербурга. 2019. № 2. C. 62-65.
26. Громова О.А., Торшин И.Ю., Гарасько Е.А. Молекулярные механизмы топического назначения витамина С в лечении бактериального вагиноза // Акушерство и гинекология. 2010. № 11. C. 37-42.
27. O'Hanlon D. E., Moench V. R., Cone R. A. In vaginal fluid, bacteria associated with bacterial vaginosis can be suppressed with lactic acid but not hydrogen peroxide // BMC infectious diseases. 2011. Vol. 11, no. 1. P. 1-8.
28. Gelber S. E., Aguilar J. L., Lewis K. L., Ratner A. J. Functional and phylogenetic characterization of Vaginolysin, the human-specific cytolysin from Gardnerella vaginalis // Journal of bacteriology. 2008. Vol. 190, no. 11. P. 3896-3903.
29. Кира Е.Ф., Молчанов О.Л., Семенова К.Е. Биологическая роль молочной кислоты в обеспечении стабильности микроэкосистемы влагалища // Акушерство и гинекология. 2014. № 12. C. 31-36.
30. Bjarnsholt T., Alhede M., Jensen P. 0., Nielsen A. K., Johansen H. K., Hom0e P., №iby N., Givskov M., Kirketerp-M0ller K. Antibiofilm properties of acetic acid // Advances in wound care. 2015. Vol. 4, no. 7. P. 363-372.
31. Atassi F., Brassart D., Grob P., Graf F., Servin A. L. Lactobacillus strains isolated from the vaginal microbiota of healthy women inhibit Prevotella bivia and Gardnerella vaginalis in coculture and cell culture // FEMS Immunology & Medical Microbiology. 2006. Vol. 48, no. 3. P. 424-432.
32. Santos C. M., Pires M. C., Leao T. L., Hernandez Z. P., Rodriguez M. L., Martins A. K., Miranda L. S., Martins F. S., Nicoli J. R. Selection of Lactobacillus strains as potential probiotics for vaginitis treatment // Microbiology. 2016. Vol. 162, no. 7. P. 1195-1207.
33. Липова Е.В., Болдырева М.Н., Трофимов Д.Ю., Витвицкая Ю.Г., Чухриенко И.Ю., Мирзоянц М.А. Урогенитальные инфекции, обусловленные условно-патогенной биотой у женщин репродуктивного возраста (клинико-лабораторная диагностика) : пособие для врачей. М., 2009. 30 с.
34. Чеботарь И.В. Механизмы антибиопленочного иммунитета // Вестник Российской академии медицинских наук. 2012. Т. 67, № 12. C. 22-29.
35. Cianci A., Giordano R., Delia A., Grasso E., Amodeo A., De Leo V., Caccamo F. Efficacy of Lactobacillus Rhamnosus GR-1 and of Lactobacillus Reuteri RC-14 in the treatment and prevention of vaginoses and bacterial vaginitis relapses // Minerva ginecologica. 2008. Vol. 60, no. 5. P. 369-376.
36. Tripathi P. Beaussart A., Alsteens D., Dupres V., Claes I., Von Ossowski I., de Vos W. M., Palva A., Lebeer S., Vanderleyden J., Dufrene Y. F. Adhesion and nanomechanics of pili from the probiotic Lactobacillus rhamnosus GG // ACS nano. 2013. Vol. 7, no. 4. P. 3685-3697.
37. Sullan R. M. A., Beaussart A., Tripathi P, Derclaye S., El-Kirat-Chatel S., Li J. K., Lebeer S., Vanderleyden J., Dufrene Y. F. Single-cell force spectroscopy of pili-mediated adhesion // Nanoscale. 2014. Vol. 6, no. 2. P 1134-1143.
38. Станько Д.Э., Ляликов P. А., Штабинская Т.Т. Особенности локального иммунитета шейки матки у женщин с бактериальным вагинозом на фоне неосложненной цервикальной эктопии // Репродуктивное здоровье. Восточная Европа. 2017. Т. 7. № 2. C. 307-308.
39. References
40. Mayorov M. V, Zhuchenko R. I., Cherniak O. L. Bacterial vaginosis: practical aspects of etiology, diagnosis and treatment. Medicinskie aspekty zdorov'ya zhenshchiny = Medical aspects of women's health. 2014; (2): 55-61. (In Russ.).
41. Piyathilake C. J., Ollberding N. J., Kumar R., Macaluso M., Alvarez R. D., Morrow C. D. Cervical microbiota associated with higher grade cervical intraepithelial neoplasia in women infected with high-risk human papillomaviruses. Cancer Prevention Research. 2016; 9 (5): 357-366.
42. Brotman R. M., Shardell M. D., Gajer P., Tracy J. K., Zenilman J. M., Ravel J., Gravitt P. E. Interplay between the temporal dynamics of the vaginal microbiota and human papillomavirus detection. The Journal of infectious diseases. 2014; 210 (11): 1723-1733.
43. Donmez H. G., Sahal G., Akgor U., Cagan M., Ozgul N., Beksac M. S. The relationship between the presence of HPV infection and biofilm formation in cervicovaginal smears. Infection. 2020; 48 (5): 735-740.
44. Tomas M., Palmeira-de-Oliveira A., Simoe, S., Martinez-de-Oliveira J., & Palmeira-de-Oliveira R. Bacterial vaginosis: Standard treatments and alternative strategies. International journal of pharmaceutics. 2020; 587: 119659.
45. Coudray M. S., Madhivanan P. Bacterial vaginosis - A brief synopsis of the literature. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2020; 245: 143-148.
46. Fredricks D. N., Fiedler T. L., Thomas K. K., Mitchell C. M., Marrazzo, J. M. Changes in vaginal bacterial concentrations with intravaginal metronidazole therapy for bacterial vaginosis as assessed by quantitative PCR. Journal of clinical microbiology. 2009; 47 (3): 721-726.
47. Sherrard J., Wilson J., Donders G., Mendling W., Jensen J. S. 2018 European (IUSTI/WHO) International Union against sexually transmitted infections (IUSTI) World Health Organisation (WHO) guideline on the management of vaginal discharge. International journal of STD & AIDS. 2018; 29 (13): 1258-1272.
48. Workowski K. A., Bachmann L. H., Chan P A., Johnston C. M., Muzny C. A., Park I., Reno H., Zenilman J. M., Bolan, G A. Sexually transmitted infections treatment guidelines, 2021. MMWR Recommendations and Reports. 2021; 70 (4): 1.
49. Kira E. F., Korshakova N. Y., Semenova K. E. The effectiveness of vaginal suppositories with lactic acid in the monotherapy of bacterial vaginosis. Reproduktivnoe zdorov'e. Vostochnaya Evropa: mezhdunarodnyj nauchnoprakticheskij zhurnal = Reproductive Health. Eastern Europe: an international scientific and practical journal. 2018; 8 (6): 771-778. (In Russ.).
50. Kira E. F. Bacterial vaginosis. Moscow: MIA Publishing House; 2012, 472 p. (in Russ).
51. Garifullov G. G., Gatina E. B., Shigaev E. P. Some aspects of infectious complications during arthroplasty. Prakticheskaya medicina = Practical medicine. 2012; 1 (3): 13-16. (In Russ.).
52. Xia Q., Cheng L., Zhang H., Sun S., Liu F., Li H., Yuan J, Liu Z., Diao Y. Identification of vaginal bacteria diversity and it's association with clinically diagnosed bacterial vaginosis by denaturing gradient gel electrophoresis and correspondence analysis. Infection, Genetics and Evolution. 2016; 44: 479-486.
53. Muzny C. A., Taylor C. M., Swords W. E., Tamhane A., Chattopadhyay D., Cerca N., Schwebke J. R. An updated conceptual model on the pathogenesis of bacterial vaginosis. The Journal of infectious diseases. 2019; 220 (9): 1399-1405.
54. Patterson J. L., Stull-Lane A., Girerd P. H., Jefferson K. K. Analysis of adherence, biofilm formation and cytotoxicity suggests a greater virulence potential of Gardnerella vaginalis relative to other bacterial-vaginosis-associated anaerobes. Microbiology. 2010; 156 (2): 392.
55. Machado A., Cerca N. Influence of biofilm formation by Gardnerella vaginalis and other anaerobes on bacterial vaginosis. The Journal of infectious diseases. 2015; 212 (12): 1856-1861.
56. Mitchell C., Fredricks D., Agnew K., Hitti J. Hydrogen peroxide-producing lactobacilli are associated with lower levels of vaginal interleukin-1p, independent of bacterial vaginosis. Sex. Transm. Dis. 2015; 42 (7): 358-363.
57. Doerflinger, S.Y. Bacteria in the vaginal microbiome alter the innate immune response and barrier properties of the human vaginal epithelia in a species-specific manner. The Journal of infectious diseases. 2014; 209 (12): 1989-1999.
58. Vitali B., Cruciani F., Picone G., Parolin C., Donders G., Laghi L. Vaginal microbiome and metabolome highlight specific signatures of bacterial vaginosis. European Journal of Clinical Microbiology & Infectious Diseases. 2015; 34 (12): 2367-2376.
59. Swidsinski A., Mendling W., Loening-Baucke V., Ladhoff A., Swidsinski S., Hale L. P., Lochs H. Adherent biofilms in bacterial vaginosis. Obstetrics & Gynecology. 2005; 106 (5): 1013-1023.
60. McMillan A., Dell M., Zellar M. P., Cribby S., Martz S., Hong E., Fu J., Abbas A., Dang T., Miller W., Reid G. Disruption of urogenital biofilms by lactobacilli. Colloids Surf B Biointerfaces. 2011; 86 (1): 58-64. doi: m.m16/j.colsurfb.20n.03.016.
61. Beigi R. H., Austin M. N., Meyn L. A., Krohn M. A., Hillier S. L. Antimicrobial resistance associated with the treatment of bacterial vaginosis. American journal of obstetrics and gynecology. 2004; 191 (4): 1123-1129.
62. Alves P., Castro J., Sousa C., Cereija T. B., Cerca N. Gardnerella vaginalis outcompetes 29 other bacterial species isolated from patients with bacterial vaginosis, using in an in vitro biofilm formation model. The Journal of infectious diseases. 2014; 210 (4): 593-596.
63. Manukhin I. B., Firichenko S. V., Smirnova S. O., Vuchenovich Yu. D. Vaginal microbiota: diagnosis, impact on women's health and correction of disorders. Training manual for physicians, clinical residents, postgraduate interns. Moscow : GlavPrint Publishers; 2015: 61-62. (In Russ.).
64. Molchanov O.L. Pathogenetic features and clinic of bacterial vaginosis. Akusherstvo i Ginekologiya SanktPeterburga = Obstetrics and Gynecology St. Petersburg. 2019; (2): 62-65. (In Russ.).
65. Gromova O. A., Torshin I. Yu., Garasko E. A.. Molecular mechanisms of vitamin C topical administration in the treatment of bacterial vaginosis. Akusherstvo i ginekologiya = Obstetrics and Gynecology. 2010; (11): 37-42. (In Russ.).
66. O'Hanlon D. E., Moench V. R., Cone R. A. In vaginal fluid, bacteria associated with bacterial vaginosis can be suppressed with lactic acid but not hydrogen peroxide. BMC infectious diseases. 2011; 11 (1): 1-8.
67. Gelber S. E., Aguilar J. L., Lewis K. L., Ratner A. J. Functional and phylogenetic characterization of Vaginolysin, the human-specific cytolysin from Gardnerella vaginalis. Journal of bacteriology. 2008; 190 (11): 3896-3903.
68. Kira E. F., Molchanov O. L., Semenova K. E. The biological role of lactic acid in the stability of the vaginal microecosystem. Akusherstvo i ginekologiya = Obstetrics and Gynecology. 2014; (12): 31-36. (In Russ.).
69. Bjarnsholt T., Alhede M., Jensen P. 0., Nielsen A. K., Johansen H. K., Homne P., Heiby N., Givskov M., Kirketerp-Meller K. Antibiofilm properties of acetic acid. Advances in wound care. 2015; 4 (7): 363-372.
70. Atassi F., Brassart D., Grob P., Graf F., Servin A. L. Lactobacillus strains isolated from the vaginal microbiota of healthy women inhibit Prevotella bivia and Gardnerella vaginalis in coculture and cell culture. FEMS Immunology & Medical Microbiology. 2006; 48 (3): 424-432.
71. Santos C. M., Pires M. C., Leao T. L., Hernandez Z. P., Rodriguez M. L., Martins A. K., Miranda L.S., Martins F.S., Nicoli J. R. Selection of Lactobacillus strains as potential probiotics for vaginitis treatment. Microbiology. 2016; 162 (7): 1195-1207.
72. Lipova E. V., Boldyreva M. N., Trofimov D. Ju., Vitvickaja Ju. G., Chuhrienko I. Ju., Mirzojanc M. A. Urogenital infections caused by conditionally pathogenic biota in women of reproductive age (clinical and laboratory diagnosis): guide for doctors. Moscow; 2009. 30 p. (In Russ.).
73. Chebotar I. V. Mechanisms of antibiofilm immunity. Vestnik Rossijskoj akademii medicinskih nauk = Bulletin of the Russian Academy of Medical Sciences. 2012; 67 (12): C. 22-29. (In Russ.).
74. Cianci A., Giordano R., Delia A., Grasso E., Amodeo A., De Leo V., Caccamo F. Efficacy of Lactobacillus Rhamnosus GR-1 and of Lactobacillus Reuteri RC-14 in the treatment and prevention of vaginoses and bacterial vaginitis relapses. Minerva ginecologica. 2008; 60 (5): 369-376.
75. Tripathi P. Beaussart A., Alsteens D., Dupres V., Claes I., Von Ossowski I., de Vos W. M., Palva A., Lebeer S., Vanderleyden J., Dufrene Y. F. Adhesion and nanomechanics of pili from the probiotic Lactobacillus rhamnosus GG. ACS nano. 2013; 7 (4): 3685-3697.
76. Sullan R. M. A., Beaussart A., Tripathi P., Derclaye S., El-Kirat-Chatel S., Li J. K., Lebeer S., Vanderleyden J., Dufrene Y. F. Single-cell force spectroscopy of pili-mediated adhesion. Nanoscale. 2014; 6 (2): 1134-1143.
77. Stanko D. E., Lyalikov P. A., Shtabinskaya T. T. Features of local cervical immunity in women with bacterial vaginosis against a background of uncomplicated cervical ectopia. Reproduktivnoe zdorov'e. Vostochnaya Evropa = Reproductive Health. Eastern Europe. 2017; 7 (2): C. 307-308. (In Russ.).